av/celldex-therapeutics--big.svg

NASDAQ:CLDX

Celldex

  • Stock

USD

Last Close

39.94

17/05 20:00

Market Cap

2.00B

Beta: 2.11

Volume Today

438.32K

Avg: 647.39K

PE Ratio

−15.31

PFCF: −20.78

Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
4.11M
-
3.59M
12.77%
5.48M
52.82%
6.79M
23.83%
12.74M
87.78%
9.54M
25.15%
3.57M
62.54%
7.42M
107.61%
4.65M
37.30%
2.36M
49.32%
6.88M
192.02%
cost of revenue
2.33M
-
42.67M
-
42.53M
0.32%
3.07M
92.79%
1.40M
54.37%
3.01M
114.86%
gross profit
1.78M
-
3.59M
101.80%
5.48M
52.82%
6.79M
23.83%
12.74M
87.78%
9.54M
25.15%
-39.10M
509.93%
-35.12M
10.19%
1.58M
104.51%
957K
39.55%
3.88M
304.91%
selling and marketing expenses
general and administrative expenses
14.80M
-
20.62M
39.29%
33.84M
64.08%
35.98M
6.33%
25.00M
30.51%
19.27M
22.93%
15.43M
19.94%
14.46M
6.29%
20.49M
41.73%
27.20M
32.74%
30.91M
13.68%
selling general and administrative expenses
14.80M
-
20.62M
39.29%
33.84M
64.08%
35.98M
6.33%
25.00M
30.51%
19.27M
22.93%
15.43M
19.94%
14.46M
6.29%
20.49M
41.73%
27.20M
32.74%
30.91M
13.68%
research and development expenses
67.40M
-
104.38M
54.87%
100.17M
4.03%
102.73M
2.55%
96.17M
6.38%
66.45M
30.91%
42.67M
35.78%
42.53M
0.32%
53.31M
25.34%
82.26M
54.30%
115.00M
39.81%
other expenses
1.01M
-
1.01M
0%
1.01M
0%
997K
1.58%
896K
10.13%
224K
75%
42.70M
18,964.73%
54.02M
26.48%
55.38M
2.52%
90.34M
63.14%
130.23M
44.16%
cost and expenses
85.55M
-
126.02M
47.30%
135.02M
7.15%
139.70M
3.47%
122.07M
12.62%
85.94M
29.60%
58.10M
32.40%
56.99M
1.91%
73.80M
29.49%
109.45M
48.31%
148.93M
36.06%
operating expenses
83.22M
-
126.02M
51.43%
135.02M
7.15%
139.70M
3.47%
122.07M
12.62%
85.94M
29.60%
58.10M
32.40%
56.99M
1.91%
73.80M
29.49%
109.45M
48.31%
145.92M
33.31%
interest expense
927K
-
15.97M
-
151.09M
845.97%
-2.91M
-
ebitda
-78.50M
-
-121.42M
54.68%
-130.87M
7.79%
-136.31M
4.15%
-96.03M
29.55%
-635K
99.34%
-58.17M
9,060.94%
-38.20M
34.34%
-67.56M
76.87%
-101.87M
50.78%
-139.03M
36.49%
operating income
-81.44M
-
-122.43M
50.33%
-129.54M
5.81%
-132.92M
2.61%
-121.53M
8.57%
-156.44M
28.73%
-55.03M
64.82%
-63.35M
15.12%
-71.24M
12.45%
-115.23M
61.75%
-142.04M
23.26%
depreciation and amortization
2.94M
-
1.01M
65.60%
1.01M
0%
997K
1.58%
5.31M
432.60%
224K
95.78%
-3.14M
1,502.23%
25.16M
900.92%
3.69M
85.35%
13.37M
262.74%
3.01M
77.50%
total other income expenses net
819K
-
4.35M
431.14%
2.34M
46.11%
4.39M
87.12%
-7.99M
282.08%
-75.55M
845.97%
4.15M
105.50%
2.41M
42.04%
505K
79.02%
2.91M
476.04%
613K
78.93%
income before tax
-81.55M
-
-118.08M
44.79%
-127.20M
7.72%
-128.53M
1.05%
-117.31M
8.73%
-151.95M
29.52%
-50.88M
66.52%
-60.95M
19.79%
-70.74M
16.06%
-112.33M
58.79%
-141.43M
25.91%
income tax expense
-819K
-
-4.35M
431.14%
-2.34M
46.11%
-8.77M
274.23%
-24.28M
176.81%
-765K
96.85%
-506K
33.86%
-1.17M
130.63%
-227K
80.55%
10.46M
4,707.05%
net income
-81.55M
-
-118.08M
44.79%
-127.20M
7.72%
-128.53M
1.05%
-93.03M
27.62%
-151.18M
62.51%
-50.37M
66.68%
-59.78M
18.68%
-70.51M
17.95%
-122.78M
74.13%
-141.43M
15.19%
weighted average shs out
5.32M
-
5.96M
12.06%
6.47M
8.56%
6.77M
4.61%
8.57M
26.61%
10.44M
21.85%
14.51M
38.93%
29.64M
104.32%
42.87M
44.64%
46.89M
9.37%
48.45M
3.33%
weighted average shs out dil
5.32M
-
5.96M
12.06%
6.47M
8.56%
6.77M
4.61%
8.57M
26.61%
10.44M
21.84%
14.51M
38.93%
29.64M
104.32%
42.87M
44.64%
46.89M
9.37%
48.45M
3.33%
eps
-15.33
-
-19.81
29.22%
-19.66
0.76%
-18.99
3.41%
-10.86
42.81%
-14.48
33.33%
-3.47
76.04%
-2.02
41.79%
-1.64
18.81%
-2.62
59.76%
-2.92
11.45%
epsdiluted
-15.33
-
-19.81
29.22%
-19.66
0.76%
-18.99
3.41%
-10.86
42.81%
-14.48
33.33%
-3.47
76.04%
-2.02
41.79%
-1.64
18.81%
-2.62
59.76%
-2.92
11.45%

All numbers in USD (except ratios and percentages)